World Muscle Society 2024 (WMS)
BackInitial Data From the ACHIEVE Trial of DYNE-101 in Adults With Myotonic Dystrophy Type 1 (DM1) (poster)
Initial Data From the DELIVER Trial of DYNE-251 in Males With DMD Mutations Amenable to Exon 51 Skipping (poster)